Remission of lupus nephritis: the trajectory of histological response in successfully treated patients

被引:8
|
作者
Malvar, Ana [1 ]
Alberton, Valeria [1 ]
Lococo, Bruno [1 ]
Lourenco, Maria [1 ]
Martinez, Joaquin [1 ]
Burna, Lucrecia [1 ]
Besso, Celeste [1 ]
Navarro, Jordi [1 ]
Nagaraja, Haikady N. [2 ]
Khatiwada, Aastha [3 ]
Wolf, Bethany [4 ]
Rovin, Brad [5 ]
机构
[1] Hosp Fernandez, Nephrol Unit, Buenos Aires, Argentina
[2] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH USA
[3] Natl Jewish Hlth, Dept Biostat & Bioinformat, Denver, CO USA
[4] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA
[5] Ohio State Univ, Wexner Med Ctr, Internal Med Nephrol, Columbus, OH 43210 USA
来源
LUPUS SCIENCE & MEDICINE | 2023年 / 10卷 / 01期
关键词
lupus nephritis; inflammation; autoimmune diseases; CLASSIFICATION; INCIDENT;
D O I
10.1136/lupus-2023-000932
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThis study investigated changes in kidney histology over time in patients with lupus nephritis (LN) undergoing immunosuppressive treatment.MethodsPatients with proliferative +/- membranous LN were studied. After a diagnostic kidney biopsy (Bx1), patients had protocol biopsy 2 (Bx2) at 9 (6-15) months and protocol biopsy 3 (Bx3) at 42 (28-67) months. Kidney histological activity and chronicity indices (AI, CI) were measured.ResultsAI declined in a biphasic fashion, falling rapidly between Bx1 and Bx2 and then more slowly between Bx2 and Bx3. Patients were divided into those who achieved histological remission, defined as an AI=0 at Bx3 (group 1), and those with persistent histological activity (AI >0) at Bx3 (group 2). The early decline in AI was 1.6 times greater (95% CI 1.30, 1.91) in group 1 than group 2 (p=0.01). Between Bx2 and Bx3, the AI decline was 2.19-fold greater (95% CI 2.09, 2.29) in group 1 versus group 2 (p=7.34x10(-5)). Individual histological components of the AI resolved at different rates. Inflammatory lesions like glomerular crescents, karyorrhexis and necrosis mostly resolved by Bx2, whereas endocapillary hypercellularity, subendothelial hyaline deposits and interstitial inflammation resolved slowly, accounting for residual histological activity at biopsy 3 in group 2. In contrast, CI increased rapidly, by 0.15 units/month between Bx1 and Bx2, then plateaued. There were no differences in the rate of accumulation of chronic damage between group 1 and group 2. The increase in CI was significantly related to the severity of glomerular crescents (p=0.044), subendothelial hyaline deposits (p=0.002) and interstitial inflammation (p=0.015) at Bx1.ConclusionsLN histological activity takes months to years to resolve, providing a rationale for the need of long-term, well-tolerated maintenance immunosuppression. Despite responding, LN kidneys accrue chronic damage early during treatment. This finding provides an explanation for the association of chronic progressive kidney disease with recurrent episodes of LN.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Prognostic factors for treatment response in patients with lupus nephritis
    Miranda-Hernandez, Dafhne
    Cruz-Reyes, Claudia
    Angeles, Ulises
    Javier Jara, Luis
    Angel Saavedra, Miguel
    REUMATOLOGIA CLINICA, 2014, 10 (03): : 164 - 169
  • [42] A single centre experience of lupus nephritis patients treated with plasmapheresis
    Rosle, D. Che
    Kong, C. T. Norella
    Halim, G. Abd
    Rashidi, S.
    Loo, C. Y.
    Rozita, M.
    Pang, K. S.
    Muhaizan, W. M. Wam
    Arbaiyah, B.
    Rahimah
    Haslinda, Nor
    NEPHROLOGY, 2008, 13 : A46 - A47
  • [43] LONGTERM SURVIVAL OF LUPUS NEPHRITIS PATIENTS TREATED WITH AZATHIOPRINE AND PREDNISONE
    BARNETT, EV
    DORNFELD, L
    LEE, DBN
    LIEBLING, MR
    JOURNAL OF RHEUMATOLOGY, 1978, 5 (03) : 275 - 287
  • [44] NEOANTIGEN RESPONSE IN SUCCESSFULLY TREATED LYMPHOMA PATIENTS
    KING, GW
    GROZEA, P
    LOBUGLIO, AF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 91 - 91
  • [45] Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis
    Gatto, Mariele
    Frontini, Giulia
    Calatroni, Marta
    Reggiani, Francesco
    Depascale, Roberto
    Cruciani, Claudio
    Quaglini, Silvana
    Sacchi, Lucia
    Trezzi, Barbara
    Bonelli, Grazia Dea
    L'Imperio, Vincenzo
    Vaglio, Augusto
    Furlan, Claudia
    Zen, Margherita
    Iaccarino, Luca
    Sinico, Renato Alberto
    Doria, Andrea
    Moroni, Gabriella
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (04): : 1047 - 1056
  • [46] Plasma CD147 reflects histological features in patients with lupus nephritis
    Maeda-Hori, M.
    Kosugi, T.
    Kojima, H.
    Sato, W.
    Inaba, S.
    Maeda, K.
    Nagaya, H.
    Sato, Y.
    Ishimoto, T.
    Ozaki, T.
    Tsuboi, N.
    Muro, Y.
    Yuzawa, Y.
    Imai, E.
    Johnson, R. J.
    Matsuo, S.
    Kadomatsu, K.
    Maruyama, S.
    LUPUS, 2014, 23 (04) : 342 - 352
  • [47] IMPORTANCE OF RACE AND CLINICAL AND HISTOLOGICAL FACTORS IN 1 66 PATIENTS WITH LUPUS NEPHRITIS
    AUSTIN, HA
    BOUMPAS, DT
    VAUGHAN, EM
    BALOW, JE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 346 - 346
  • [48] HISTOLOGICAL AND SEROLOGICAL CHARACTERISTICS CONTRIBUTE TO DIVERGENT OUTCOMES FOR INDIGENOUS PATIENTS WITH LUPUS NEPHRITIS
    Nossent, J.
    Raymond, W.
    Kang, A.
    Ognejovic, M.
    Chakera, A.
    Wong, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1268 - 1268
  • [49] Evaluation of Clinical, Histological and Biomarker Response After Induction Treatment of Lupus Nephritis (LN)
    Egypto, Danielle
    Neto, Edgard Reis
    Carlesso, Guilherme
    Andrade, Luis
    Moura, Luiz
    Calderaro, Debora
    Sato, Emilia
    Sato, Emilia Inoue
    dos Reis Neto, Edgar Torres
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1309 - 1311
  • [50] Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis
    Fava, Andrea
    Buyon, Jill
    Magder, Laurence
    Hodgin, Jeff
    Rosenberg, Avi
    Demeke, Dawit S.
    Rao, Deepak A.
    Arazi, Arnon
    Celia, Alessandra Ida
    Putterman, Chaim
    Anolik, Jennifer H.
    Barnas, Jennifer
    Dall'Era, Maria
    Wofsy, David
    Furie, Richard
    Kamen, Diane
    Kalunian, Kenneth
    James, Judith A.
    Guthridge, Joel
    Atta, Mohamed G.
    Trujillo, Jose Monroy
    Fine, Derek
    Clancy, Robert
    Belmont, H. Michael
    Izmirly, Peter
    Apruzzese, William
    Goldman, Daniel
    Berthier, Celine C.
    Hoover, Paul
    Hacohen, Nir
    Raychaudhuri, Soumya
    Davidson, Anne
    Diamond, Betty
    Petri, Michelle
    JCI INSIGHT, 2024, 9 (02)